Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Obesity. Found 12 abstracts

Fisher SG, Devlin A. Development of an urban community-based cohort to promote health disparities research. International journal of public health. 2019 Sep;64(7):1107-15.
Christian AH, O'Malley D, Barac A, Miller SM, Hudson SV. Cardiovascular risk and communication among early stage breast cancer survivors. Patient education and counseling. 2017 Jul;100(7):1360-6.   PMCID: PMC5568653
Dubey B, Jackson M, Zeigler-Johnson C, Devarajan K, Flores-Obando RE, McFarlane-Anderson N, Tulloch-Reid M, Aiken W, Kimbro K, Jones D, Kidd LR, Ragin C. Inflammation polymorphisms and prostate cancer risk in Jamaican men: Role of obesity/body size. Gene. 2017 Sep 10;636:96-102.   PMCID: PMC5645041
Jain R, Dotan E. Nutrition and Aging: a Practicing Oncologist's Perspective. Current oncology reports. 2017 Sep 07;19(11):71.
Jain R, Dotan E. Nutrition and Aging: a Practicing Oncologist’s Perspective. Current oncology reports. 2017 Sep 07;19(11):71.
Virtue A, Johnson C, Lopez-Pastrana J, Shao Y, Fu H, Li X, Li YF, Yin Y, Mai J, Rizzo V, Tordoff M, Bagi Z, Shan H, Jiang X, Wang H, Yang XF. MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease: A NOVEL MOUSE MODEL OF OBESITY PARADOX. The Journal of biological chemistry. 2017 Jan 27;292(4):1267-87.   PMCID: PMC5270472
Haggerty AF, Huepenbecker S, Sarwer DB, Spitzer J, Raggio G, Chu CS, Ko E, Allison KC. The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancer. Gynecol Oncol. 2016 Feb;140(2):239-44.
Asge Technology Committee, Kethu SR, Banerjee S, Barth BA, Desilets DJ, Kaul V, Pedrosa MC, Pfau PR, Pleskow DK, Tokar JL, Wang A, Song LM, Rodriguez SA. Endoluminal bariatric techniques. Gastrointestinal endoscopy. 2012 Jul;76(1):1-7.   PMCID: not NIH funded
Brewster AM, Etzel C, Zhou R, Wong Y, Edge S, Blayney DW, Wilson J, Hudis C, Ottesen R, Hughes ME, Weeks JC, Theriault RL. The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers. Breast Cancer Research and Treatment. 2011 Dec;130(3):897-904.   PMCID: NIHMS395682
Gaudet MM, Falk RT, Gierach GL, Lacey JV, Graubard BI, Dorgan JF, Brinton LA. Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?. Cancer Epidemiology. 2010 Oct;34(5):580-6.   PMCID: PMCID: PMC2949443 [Available on 2011/10/1]
Russo J, Lareef MH, Tahin Q, Hu YF, Slater C, Russo IH. The role of estrogens in human breast cancer: a mechanistic view. Menopause: Hormones and Cancer, Proceedings of the International Symposium of the Portuguese Menopause Society, 2nd, Estoril, Portugal, Mar 16-17, 2001. 2002 Jan;:23-36.
Summers JB, Kaminski JM. Nutrition, physical activity, and obesity. Lancet (London, England). 2002 Oct 19;360(9341):1249.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Obesity

Obesity Overnutrition Aging Elderly methods Nutrition Human therapy Cachexia Biomarkers Malnutrition Epidemiology Breast cancer Hormone replacement therapy Single nucleotide polymorphisms Mammary gland (carcinoma health syndrome Technology-based intervention inflammation obesity fat Infant pathology liver older women therapeutic use determinants atherosclerosis Atherosclerosis mortality including toxicity) Estrogens Role: ADV (Adverse effect-BSU (Biological study-unclassified)-BIOL (Biological study) (estrogens and hormone replacement therapy assocd with obesity as risk assessment for postmenopausal women with breast cancer) Botulinum Toxins Mice plasminogen-activator adipose-tissue Breast neoplasms Child Adipokines review estrogen replacement therapy breast cancer Child Nutrition Endometrial cancer Apolipoproteins E Animal Disease Models Patient education deficiency cells etiology legislation & jurisprudence Nutrition Policy genetics ethnicity Health disparities Gastric Balloon disparities Black Health Status Disparities survival Prostheses and Implants estrogens and hormone replacement therapy assocd with obesity as risk assessment for postmenopausal women with breast cancer) Male Standard-of-care Community Participation adverse effects Healthcare Disparities chemically resistin levels Menopause (postmenopause Female Cohort Studies Risk Non-alcoholic Fatty Liver Disease Minority Groups Health Promotion 1987 arlson me-journal of chronic diseases-v40-p373 serum adiponectin care United States MicroRNAs Gastrointestinal Endoscopy carcinoma Knockout Mice White Adipose Tissue Cohort Weight loss intervention metabolic instrumentation Food Services Prostate cancer Neurotoxins Ethnic Groups metabolism Aid to Families with Dependent Children chemically induced organization & administration Philadelphia Socioeconomic Factors Adult Urban epidemiology microRNA (miRNA) pharmacology Research Middle Aged Adjuvant Infant Nutrition Dietary Fats Hypertension Chemotherapy Risk assessment (estrogens and hormone replacement therapy assocd with obesity as risk assessment for postmenopausal women with breast cancer) standards release Communication Cardiovascular estrogen Waist to hip ratio induced Community-based
Last updated on Wednesday, March 04, 2020